Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 29, 2015FDA Updates March 2015 Safety Alert on CSTD Compatibility for Treanda® Injection
September 29, 2015 - Today BD (Becton, Dickinson and Company), notified customers that the U.S. Food and Drug Administration (FDA) has updated its March 2015 Safety Alert based on Teva...
-
Sep 24, 2015
SPARKS, MD., Sept. 24, 2015 – BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the availability of the U.S. Food...
-
Sep 16, 2015Vyntus® WALK Wirelessly Assesses Functional Exercise Capacity
SAN DIEGO, CA, Sept. 16, 2015 – CareFusion, a BD company (NYSE: BDX), announces the availability of a new respiratory diagnostics tool that is a complete mobile solution for assessing functional...
-
Sep 15, 2015
CHICAGO, IL, Sept. 15, 2015 – The Product Development and Management Association (PDMA), the premier global advocate for product development and management professionals, announced today that it...
-
Sep 14, 2015
SEOUL, KOREA and BALTIMORE, MD, Sept. 14, 2015 – Seegene Inc. (096530.KQ) and BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) today announced that they have entered...
-
Sep 3, 2015TechValidate Survey Supports Benefits of Pyxis ES Platform for Health System Pharmacy Operations
SAN DIEGO, CA, Sept. 3, 2015 – PRNewswire/ -- CareFusion, a BD company (NYSE: BDX), announces that its enterprise-level Pyxis® ES platform, developed to help hospitals and health systems better...
-
Aug 27, 2015Commitments include cash and product donations through AmeriCares, Direct Relief, Heart to Heart International, Project HOPE, Save the Children and UNICEF
FRANKLIN LAKES, N.J., Aug. 27, 2015 – BD (Becton, Dickinson and Company), a leading global medical technology company, has committed $700,000 in aid to assist those affected by the April 2015...
-
Aug 25, 2015
FRANKLIN LAKES, N.J., Aug. 25, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed...
-
Aug 6, 2015- Announces adjusted revenues of $3.133 billion, an increase of 45.2 percent, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues of $3.120 billion increased 44.6 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June...
-
Jul 28, 2015
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60 cents per common share, payable on September 30, 2015 to holders of record on...